Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial. [electronic resource]
Producer: 20190218Description: 2603-2609 p. digitalISSN:- 1935-5548
- Aged
- Benzofurans -- adverse effects
- Cardiovascular Diseases -- epidemiology
- Cardiovascular System -- metabolism
- Chemical and Drug Induced Liver Injury -- epidemiology
- Diabetes Mellitus, Type 2 -- complications
- Diabetic Angiopathies -- epidemiology
- Double-Blind Method
- Female
- Humans
- Hypoglycemic Agents -- administration & dosage
- Male
- Middle Aged
- Sulfones -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.